Doximity (NYSE:DOCS) shares jumped as much as 10% in extended trading Tuesday after the online health company, which held its stock market debut in June, said quarterly revenue doubled.
Doximity, which provides professional networking and telehealth tools for medical professionals, doubled revenue in the quarter and said sales for the full fiscal year will be between $296.5 million and $299.5 million. That’s an annual increase of at least 43% from $206.9 million.
The company is boosting revenue by providing more targeted marketing services to drugmakers and hospitals, which can reach a specialized audience on Doximity’s news feed. Additionally, Doximity has a new telehealth offering so doctors can securely communicate with their patients.
While Doximity didn’t disclose specific revenue figures for its telehealth product, the company said it’s now serving over 30% of all U.S. physicians with its paid offering.
Doximity’s news feed includes stories the company posts from mainstream news sources and medical and scientific journals. The comments section is open to its userbase of physicians, nurse practitioners, physician assistants, medical students, pharmacists and other health-care workers.
Like other social networks, Doximity faces the challenge of handling increased misinformation related to the COVID19 vaccine and masks in the comments last week. Doximity CEO Jeff Tangney told the media after earnings on Tuesday that such claims are coming from less than 0.1% of its users.
DOCS gained $8.62, or 16.3%, to $61.55
